PharmaShots | Incisive News in 3 Shots

Subscribe Now

SpliSense

SpliSense’s IND of SPL84 Receives the US FDA’s Clearance to Conduct P-II Study for Treating Cystic Fibrosis

SpliSense’s IND of SPL84 Receives the US FDA’s Clearance to Conduct P-II Study for Treating Cystic Fibrosis

April 4, 2024

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us